Weibing Li Selected Research

Weibing Li Research Topics

Disease

7	Neoplasms (Cancer) 10/2023 - 01/2014
4	Inflammation (Inflammations) 10/2023 - 04/2011
4	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 01/2014
3	Neoplasm Metastasis (Metastasis) 10/2021 - 06/2016
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2023 - 02/2023
2	Breast Neoplasms (Breast Cancer) 06/2016 - 11/2013
2	Shock 02/2015 - 01/2014
2	Calculi (Calculus) 01/2014 - 01/2008
2	Prostatitis 04/2011 - 06/2008
2	Pain (Aches) 04/2011 - 01/2008
2	Overactive Urinary Bladder (Overactive Bladder) 11/2007 - 01/2007
1	Cystitis 01/2023
1	Hemorrhagic Cystitis 12/2022
1	Urinary Bladder Diseases (Bladder Diseases) 12/2022
1	Colorectal Neoplasms (Colorectal Cancer) 12/2022
1	Disease Progression 09/2020
1	COVID-19 09/2020
1	Thymoma (Thymic Carcinoma) 05/2020
1	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2020
1	Carcinogenesis 08/2018
1	Renal Colic 03/2018
1	Hyperesthesia 06/2015
1	Nephrolithiasis 09/2014
1	Ureteral Obstruction 07/2014
1	Hemolysis 07/2014
1	Kidney Calculi (Kidney Stone) 01/2014
1	Thrombocytopenia (Thrombopenia) 11/2013
1	Neutropenia 11/2013
1	Anemia 11/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2013
1	Hypersensitivity (Allergy) 04/2011
1	Intractable Pain 04/2011
1	Acute Kidney Injury (Acute Renal Failure) 02/2011
1	Pelvic Pain 06/2008
1	Infections 06/2008
1	Pathologic Constriction (Stenosis) 01/2008
1	Urologic Diseases (Urinary Tract Disease) 01/2008
1	Fever (Fevers) 01/2008
1	Hematuria 01/2008
1	Wounds and Injuries (Trauma) 01/2008

Drug/Important Bio-Agent (IBA)

2	Hyaluronic Acid (Hyaluronan)IBA 10/2023 - 12/2022
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 06/2016
2	2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA 02/2023 - 01/2023
2	Oxygen (Dioxygen)IBA 02/2023 - 09/2020
2	Proteins (Proteins, Gene)FDA Link 02/2023 - 09/2014
2	AndrogensIBA 04/2021 - 01/2019
1	polydopamineIBA 10/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2023
1	AntioxidantsIBA 10/2023
1	CadmiumIBA 10/2023
1	IodidesIBA 02/2023
1	HydrogelsIBA 12/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022
1	Antineoplastic Agents (Antineoplastics)IBA 12/2022
1	MatrinesIBA 12/2022
1	MicroRNAs (MicroRNA)IBA 10/2021
1	Hormones (Hormone)IBA 04/2021
1	Antiviral Agents (Antivirals)IBA 09/2020
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 05/2020
1	ent-dihydrotucumanoic acidIBA 03/2019
1	CateninsIBA 01/2019
1	VA 061 (VA061)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 11/2018
1	Janus KinasesIBA 08/2018
1	Tamsulosin (Flomax)FDA LinkGeneric 03/2018
1	Analgesics (Analgesic Drugs)IBA 03/2018
1	ezrinIBA 06/2016
1	moesinIBA 06/2016
1	radixinIBA 06/2016
1	Purinergic P2X2 ReceptorsIBA 06/2015
1	ProcalcitoninIBA 02/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2015
1	Uric Acid (Urate)IBA 09/2014
1	Hemoglobins (Hemoglobin)IBA 07/2014
1	Indicators and Reagents (Reagents)IBA 07/2014
1	Heme (Haem)IBA 07/2014
1	InflammasomesIBA 07/2014
1	Heme Oxygenase-1IBA 07/2014
1	Caspase 1 (ICE Protease)IBA 07/2014
1	CytokinesIBA 01/2014
1	GW 3965IBA 01/2014
1	Gemcitabine FDA Link 11/2013
1	Freund's AdjuvantIBA 04/2011
1	P-2 (P 2)IBA 04/2011
1	Adenosine Triphosphate (ATP)IBA 04/2011
1	CreatinineIBA 02/2011
1	Calcifying NanoparticlesIBA 06/2008
1	16S Ribosomal RNAIBA 06/2008
1	Connexin 43 (Connexin43)IBA 11/2007
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2007

Therapy/Procedure

10	Therapeutics 10/2023 - 06/2008
3	Drug Therapy (Chemotherapy) 10/2023 - 11/2013
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 01/2014 - 01/2008
1	Intravesical Administration 10/2023
1	Castration 04/2021
1	Length of Stay 01/2014
1	Operative Time 01/2014
1	Stents 01/2008
1	Percutaneous Nephrolithotomy 01/2008